Informazioni sul prodotto
ML184 is a synthetic cannabinoid drug that has been found to have low potency and activated properties. ML184 binds to the CB2 receptor, which is primarily expressed in immune cells and microglia. The binding of ML184 to the CB2 receptor may be involved in the regulation of transcriptional regulation, biological functions, and autoimmune diseases. It also has agonist binding site activity for the endocannabinoid system and can be used as an anti-inflammatory agent. This drug has also been shown to have anticancer effects, which may be due to its ability to induce apoptosis in cancer cells.
Proprietà chimiche
Richiesta tecnica su: 3D-UGB57210 ML184
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
